Translate
Ocular Therapeutix Inc
About
Ocular Therapeutix Inc (NASDAQ:OCUL) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026
Yesterday
Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences
Apr 22 2026
Ocular Therapeutix™ to Host Investor Day on June 17, 2026
Apr 13 2026
Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD
Apr 1 2026
Ocular Therapeutix™ to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April
Financials
Revenue
$51.95 M
Market Cap
$1.85 B
EPS
-1.42